The median overall survival rate for patients with tumours harbouring CTNNB1 mutations and deletions alone was significantly lower compared to the ones without (12.5 vs 77 months, log rank p = 0.0331, Fig. 5b). The gene discussed is CTNNB1; the disease is neoplasm.